Dr. Hode, CEO and co-founder of Immunophotonics Inc, has been engaged in the medical laser device industry since 1994, and the biotech industry since 2007. In parallel with his engagement in the industry he received a PhD in astrobiology in 2005 at Stockholm University, after which he took a position as a Research Associate at Portland State University. In 2007 Dr. Hode returned to industry but kept his ties to academia through a courtesy position as an Associate Research Professor at Portland State University, and more recently as a Visiting Scientist at SP Technical Research Institute of Sweden, Section of Medical Devices at the Chemistry and Materials Technology Department.
Development of InCVAX as a novel in situ autologous vaccine for metastatic cancers (Conference Presentation)
Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase II clinical trial
Interstitial laser irradiation of metastatic mammary tumors in combination with intratumoral injection of immunoadjuvant
Magnetic resonance thermometry for monitoring photothermal effects of interstitial laser irradiation
Assessment of thermal effects of interstitial laser phototherapy on mammary tumors using proton resonance frequency method
Photothermal effects in tissues induced by interstitial irradiation of near infrared laser with a cylindrical diffuser